Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
Hwa Kyung ByunNalee KimHong In YoonSeok-Gu KangSe Hoon KimJaeho ChoJong Geol BaekJong Hee ChangChang-Ok SuhPublished in: Radiation oncology (London, England) (2019)
IMRT and low PTV were significantly associated with decreased ASL incidence after RT plus temozolomide for glioblastoma. An IMRT-based strategy is necessary to enhance treatment outcomes in the immune-oncology era.